APA

Brill M. J., van Rongen A., van Dongen E. P., van Ramshorst B., Hazebroek E. J., Darwich A. S., Rostami-Hodjegan A. & Knibbe C. A. (20160811). The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery. : Pharmaceutical research.

Chicago

Brill Margreke J, van Rongen Anne, van Dongen Eric P, van Ramshorst Bert, Hazebroek Eric J, Darwich Adam S, Rostami-Hodjegan Amin and Knibbe Catherijne A. 20160811. The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery. : Pharmaceutical research.

Harvard

Brill M. J., van Rongen A., van Dongen E. P., van Ramshorst B., Hazebroek E. J., Darwich A. S., Rostami-Hodjegan A. and Knibbe C. A. (20160811). The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery. : Pharmaceutical research.

MLA

Brill Margreke J, van Rongen Anne, van Dongen Eric P, van Ramshorst Bert, Hazebroek Eric J, Darwich Adam S, Rostami-Hodjegan Amin and Knibbe Catherijne A. The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery. : Pharmaceutical research. 20160811.